Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial)
Roger Olofsson Bagge, Axel Nelson, Amir Shafazand, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 16, pp. 3042-3050
Open Access | Times Cited: 45

Showing 26-50 of 45 citing articles:

Surveillance for Metastasis in High-Risk Uveal Melanoma Patients: Standard versus Enhanced Protocols
Yağmur Seda Yeşiltaş, Emily C. Zabor, Jacquelyn Wrenn, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5025-5025
Open Access | Times Cited: 3
Recent approaches for the treatment of uveal melanoma: Opportunities and challenges
Sauban Ahmed Khan, Waleed Hassan Almalki, Swaranjeet Arora, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 193, pp. 104218-104218
Closed Access | Times Cited: 3
3‐Jahres‐Update zur Therapie mit Tebentafusp beim metastasierten Uveamelanom
Jessica C. Hassel, Carola Berking
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 3, pp. 485-487
Open Access
Lineage commitment pathways epigenetically oppose oncogenic Gαq/11-YAP signaling in dormant disseminated uveal melanoma
Rama Kadamb, Melisa Lopez Anton, Timothy J. Purwin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Repeated use of hybrid isolated chemoperfusion with melphalan in non-resectable liver malignancy
A. I. Babich, M. A. Privalov, А. Е. Демко, et al.
Siberian Journal of Oncology (2024) Vol. 23, Iss. 1, pp. 155-161
Open Access
Case report: Immunotherapy inducing unexpected overall survival in choroidal melanoma: about a case
Youssef Elhaitmy, Soukaina El Anssari, P. Fournel, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Isolated liver chemoperfusion in a patient with mesenteric leiomyosarcoma and liver metastasis
И. В. Решетов, V. A. Manukovsky, А. Е. Демко, et al.
Siberian Journal of Oncology (2024) Vol. 23, Iss. 2, pp. 126-132
Open Access
A Clinico-Genetic Score Incorporating Disease-Free Intervals and Chromosome 8q Copy Numbers: A Novel Prognostic Marker for Recurrence and Survival Following Liver Resection in Patients with Liver Metastases of Uveal Melanoma
Pascale Mariani, Gaëlle Pierron, Khadija Aït Raïs, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3407-3407
Open Access
Meeting Report From the 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Philadelphia, PA, November 2023
Rino S. Seedor, Andrew E. Aplin, Corine Bertolotto, et al.
Pigment Cell & Melanoma Research (2024)
Open Access
A safety review of recently approved and late-stage trial treatments for metastatic melanoma: systemic and regional therapies
Matthew Perez, Danielle K. DePalo, Jonathan S. Zager
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 9, pp. 789-797
Closed Access | Times Cited: 1
Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases
Joakim Karlsson, Vasu R. Sah, Roger Olofsson Bagge, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 1
The Role of Autophagy in Human Uveal Melanoma and the Development of Potential Disease Biomarkers and Novel Therapeutic Paradigms
Janney Z. Wang, Paus Paulus, Yihe Niu, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 462-462
Open Access
Treatment of Metastatic Uveal Melanoma. The Experience of a Leading Reference Center
V.V. Nazarova, Zakhra R. Magomedova, Kristina V. Orlova, et al.
Effective Pharmacotherapy (2024) Vol. 20, Iss. 5, pp. 74-79
Open Access
Reviewer #1 (Public Review): Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases

(2024)
Open Access
Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases
Joakim Karlsson, Vasu R. Sah, Roger Olofsson Bagge, et al.
(2024)
Open Access
Author response: Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases
Joakim Karlsson, Vasu R. Sah, Roger Olofsson Bagge, et al.
(2024)
Open Access
Reviewer #2 (Public Review): Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases

(2024)
Open Access
eLife assessment: Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases
Yongliang Yang
(2024)
Open Access
Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases
Joakim Karlsson, Vasu R. Sah, Roger Olofsson Bagge, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases
Joakim Karlsson, Vasu R. Sah, Roger Olofsson Bagge, et al.
(2023)
Open Access
Author Response: Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases
Joakim Karlsson, Vasu R. Sah, Roger Olofsson Bagge, et al.
(2023)
Open Access
Previous Page - Page 2

Scroll to top